RNASEH2A and colorectal cancer: To test this hypothesis, we evaluated the effect of RNaseH2A ablation on SASP-like inflammatory gene expression using a degron-mediated protein degradation system in the HCT116 colorectal cancer cell line49 (Fig. 7a).